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Background: There has been no direct comparison between an incremental and endurancewalk-
ing test to detect the relative oxygen desaturation in patients with chronic obstructive pulmo-
nary disease (COPD). This is of some importance as current guidelines have suggested that
ambulatory oxygen should only be prescribed after a standard assessment and desaturation
documented. No clear advice about the nature of the required exercise task is given. This study
therefore compared the relative desaturation between the incremental shuttle walking test
(ISWT) and the constant speed walking test (ESWT) and response to ambulatory oxygen.
Methods: Forty-one patients (29 male), mean (SD), age 71.18 (7.48) yrs, FEV1 0.85 (0.29) l with
stable COPD were recruited after completion of a 7-week pulmonary rehabilitation programme.
Patients completed a baseline (without carrying a cylinder) ISWT and ESWTand then, in random
order in double blind fashion, completed the walk tests with a cylinder of air or a cylinder of ox-
ygen. Measurements included distancewalked, oxygen saturation, heart rate, perceived breath-
lessness and exertion (Borg scale).
Results: All patients desaturated (<4% below 90%). There was no significant difference in
desaturation between the ISWT and the ESWT. There was a significant improvement in perfor-
mance with supplementary oxygen compared to cylinder air (p< 0.05) for both tests. However,
compared to the baseline walk, supplementary oxygen did not enhance the distance walked for
either test. There was a significant decrease in walking performance on both the ISWT and the
ESWT when carrying an air cylinder compared with the control walk. When comparing the per-
centage difference between oxygen and air for responders (i.e. those that achieve a 10% ormore
increase), the ESWTshowed a greater percentage change 42.1% compared to 26.1% for the ISWT.
Conclusions: This study identifies that incremental and endurance walking provokes significant
desaturation and that there is a short-term benefit of oxygen versus air in enhancing exercise116 256 3181; fax: þ44 0116 236 7768.
uhl-tr.nhs.uk (C.J. Sandland).
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Detecting oxygen desaturation in patients with COPD 1149performance. There was no significant difference in the level of desaturation between tests.
Therefore the ISWT is a suitable exercise test that can be used to evaluate desaturation and is
practically more realistic.
ª 2008 Elsevier Ltd. All rights reserved.Introduction
At present there are no clear guidelines for the type of
exercise assessment required to demonstrate suitability for
ambulatory oxygen. In the past published guidelines1 have
suggested that ambulatory oxygen should be prescribed
when there is evidence of at least 10% improvement in
either walking distance or dyspnoea score when walking
with cylinder oxygen compared with cylinder air on a stan-
dard exercise test. A more recent document based on these
guidelines describes the clinical standards for assessment
and prescription of ambulatory oxygen.2 As part of the as-
sessment walking tests should be performed to evaluate
the oxygen flow rate to correct for exercise desaturation.
These tests can be in the form of shuttle walk tests or
the 6-min walk test which examine the short-term response
to ambulatory oxygen. Endurance tests may be more sensi-
tive to the benefit of ambulatory oxygen than maximal
tests. An earlier document recommended oxygen for pa-
tients who desaturate on exercise, have an improvement
in exercise capacity and or dyspnoea with oxygen.3 How-
ever, ambulatory oxygen assessments shouldn’t solely rely
on desaturation during an exercise test. A patient may be
prescribed ambulatory oxygen it does not mean that they
are going to comply with what is recommended. An impor-
tant requirement may be the motivation to use it.3 No pub-
lication clearly recommends a precise exercise challenge
necessary to uncover desaturation or demonstrate the im-
mediate short-term benefit of ambulatory oxygen.
Different modes of physical exercise produce different
levels of oxygen de-saturation. Patients with COPD are
known to desaturate on exercise to a greater extent whilst
completing a self-paced walking test compared to cycle
ergometry.4 Others have reported that individuals desatu-
rated to a greater extent during corridor walking than an
incremental cycle test.5 Also when a group of patients un-
derwent an incremental followed by a constant work test,
9/28 showed a fall in arterial oxygen tension to 55 mmHg
or below only during the constant work test.5 Patients per-
forming a constant work rate test appear to desaturate to
a greater extent than when observed in an incremental
test.6 Consequently the type of test and mode of exercise
may influence the decision to prescribe supplementary
oxygen. It is generally assumed that supplemental oxygen
during an exercise test in COPD patients alleviates symp-
toms and improve performance.7,8 However, the relation-
ship between test conditions and domestic improvement
is unclear. This disparity between mode of testing has
also been demonstrated in bronchodilator studies.9
Maximal and endurance field walking tests are often
employed in the assessment of ambulatory oxygen, although
current guidelines don’t stipulate which test should be
used. The incremental and endurance shuttle walk testsare two such tests that are commonly used in ambulatory
oxygen assessment.
The aim of this study is to examine the level of desatura-
tion provoked after a maximal and endurance field walking
test. A second aim was to evaluate the responsiveness of the
two tests to ambulatory oxygen.
Methods
Study design
The design was a randomised, controlled, double blind
trial. The study compared oxygen desaturation and the
effect of cylinder air or ambulatory oxygen on the perfor-
mance of the incremental and the endurance shuttle walk
test.
Patient recruitment
Forty-one clinically stable patients with COPD (forced
expiratory volume in 1 s (FEV1)< 40% of predicted) ex-
smokers were recruited after completion of a 7-week pul-
monary rehabilitation programme and therefore were
familiar with exercise testing. Inclusion criteria included
patients who were hypoxic at rest (on long-term oxygen
therapy) (LTOT), and/or demonstrated exercise induced
desaturation. This was based on arterial oxygen desatura-
tion of more than 4% below 90% on a standard walking
test.2 All patients reported significant, persistent disabling
breathlessness post-rehabilitation on the MRC scale i.e. 3
and above.10
Exercise assessments
Two modes of exercise test were employed to examine
oxygen desaturation; the incremental shuttle walking
test (ISWT)11,12 and the endurance shuttle walking test
(ESWT).13 The ESWT was conducted at 85% of the predicted
peak VO2 established from their ISWT performance. During
both tests oxygen saturation and pulse were monitored us-
ing a Pulsox-3iA finger probe. In addition peak Borg breath-
lessness and perceived exertion were recorded for every
walk.14 Patients attended the hospital for three separate
visits. They completed a baseline (without carrying a
cylinder) ISWT and ESWT. Patients then completed the
walk tests with a portable cylinder of air and a portable
cylinder of oxygen (with a back pack). These two walks
were performed randomly and double blinded. The cylin-
ders weighed 3.1 kg when full with the regulator, the
dimensions were 100 mm 460 mm. Cylinder oxygen and
air were delivered using a flow rate of 2 l/min1 via a nasal
cannula. The cylinders were prefilled with oxygen or air
Table 2 Mean (m) distance and time (s) walked for the
ISWT and ESWT
1150 C.J. Sandland et al.and were only identifiable by a colour code. All walk tests
were supervised by the same blinded operator.ISWT (m) 95% CI ESWT (s) 95% CI
Control 221.5
(111.8)
186.2e256.7 253.4
(148.8)
207.7e299.1
Oxygen 224.0
(123.0)
184.7e263.3 272.5
(252.6)
190.1e354.4
Air 192.4
(105.5)
159.1e225.8 156.0
(75.0)
132.6e179.9Statistical analysis
Differences in ISWT distance walked (m), ESWT duration
walked (s) and end SpO2 levels were assessed using ANOVA.
Scheffe Post hoc test was used to identify where any differ-
ences lay. The Wilcoxon signed ranks test was used to as-
sess the end Borg breathlessness and perceived exertion
scores. Statistical significance was taken at the 95% level.
Data was analysed using SPSS.V.14. Using previous guide-
lines a responder was prospectively identified as an individ-
ual who improved walking performance by more than 10%
with cylinder oxygen compared to air.2
To detect a 5% difference in desaturation between the
ISWT and the ESWT at 80% power, 0.05 significance level 41
patients were required.
The study was approved by the Leicestershire Research
Ethics Committee with all patients providing written
consent.
Results
Patient characteristics
The characteristics of the 41 patients are presented in
Table 1. Complete study data was collected for 39 patients.Oxygen desaturation
There was no statistical difference in oxygen desaturation
between the ISWT and the ESWT at baseline, or with oxygen
or air (see Table 2). For both the ISWT and the ESWT there
was a significant improvement in desaturation (p< 0.05)
between oxygen and control and between oxygen and air
(p< 0.05). There was no difference in the mean end SpO2
with oxygen (88%) or with air (82%) for both the ISWT and
the ESWT.Exercise performance
The mean (SD) distance and duration walked for the ISWT
and ESWT, respectively, are presented in Table 2.Table 1 Patient characteristics
Parameter Patients
Subjects (n) 41
Age (yrs) 71.18 (7.45)
BMI 23.20 (8.79)
Male:female 29:12
FEV1(l) 0.85 (0.29)
Oxygen therapy 5 LTOT 3 PRN 33 none
FEV1Z forced expiratory volume in 1 s; and BMIZ body mass
index.ISWT
There was a significant reduction in performance e29.0
(44.7) m when carrying an air cylinder compared with the
control walk (p< 0.0001), (95% CI 43.1 to 14.9). There
was a significant improvement in performance, 33.2
(46.3) m with ambulatory oxygen compared to air
(p< 0.0001), 95% CI þ10.9 to þ17.9. However, compared
to the baseline, oxygen did not significantly enhance per-
formance 3.5 (44.92) m (p> 0.0001), 95% CI 10.9 to 17.9.
ESWT
To allow a direct comparison to be made with the ISWT we
converted the ESWT to metres. There was a significant
reduction in performance 94.0 (121.7) m when carrying an
air cylinder compared with the control walk (p< 0.0001),
95% CI 133.0 to 55.1. There was a significant improve-
ment in performance 112.0 (217.1) m (mean time 174 s)
with ambulatory oxygen compared to air (p< 0.03), 95%
CI 41.6e182.4. However, compared to baseline, oxygen
again did not significantly enhance performance as a group
19.4 (160.3) m (p> 0.0001), (95% CI 32.6 to 71.3) (mean
time 42 s).
Responders to cylinder oxygen
There were no statistical differences in the baseline
characteristics of responders and non-responders. For the
ISWT, 23 out of the 41 patients improved their walking by
more than 10%, for the ESWT 28 out of the 41 patients
improved by more than 10%. Twenty patients secured
benefits on both exercise tests. The variation in response
above 10% was variable, some patients increasing by 60% on
the ESWT. The mean increase on the ISWT for these
patients was 61.7 (36.1) m when walking with oxygen com-
pared to air for the responders. The improvement for the
responders on the ESWT was 173.6 s which equates to 153
(174) m. This corresponds to a mean percentage increase
of 26.1% and 42.1%, respectively (see Table 3).
Non-responders were defined as those individuals who
failed to achieve a 10% increase in either the ISWT (nZ 16)
or the ESWT (nZ 11). For both the ISWT and the ESWT
there was no overall performance benefit to ambulatory ox-
ygen for these individuals. Eight out of twenty-eight failed
to secure an improvement on the ISWT whilst achieving an
important change on the ESWT. When looking at negative
responders 3 patients showed a decrease of 10% in the ISWT
and 6 patients in the ESWTwith oxygen compared to air.
Table 3 Responders as defined by 10% improvement in
walking distance with cylinder of oxygen compared to air
ISWT (m) (nZ 23) ESWT (s) (nZ 28)
Baseline 229.1 (117.1) 273.7 (157.6)
Oxygen 242.1 (129.1) 322.1 (279.0)
Air 180.4 (108.5) 148.5 (71.5)
Mean increase
between oxygen
and air (m)
61.7 (36.1) 173.6 (225.7)
Mean increase
oxygen and
baseline (m)
13.0 (55.1) 48.5 (177.2)
Percentage
improvement
between oxygen
and air (%)
26.1 (11.2) 42.1 (20.9)
Percentage
improvement
between oxygen
and baseline (%)
2.6 (23.6) 37.4 (23.2)
Detecting oxygen desaturation in patients with COPD 1151There was no statistically significant difference for the
ISWT or the ESWT between the three groups for perceived
breathlessness or exertion scores. Fifteen out of twenty-
seven patients improved their Borg score on the ISWT and
23/31 on the ESWT with oxygen compared to air. Four
patients got worse with oxygen on the ISWT and 3 on the
ESWT. For the ISWT, patients tended to report feeling less
breathless when walking with oxygen compared to air.
However, when compared to the baseline walk patients
commonly reported feeling more breathless with either
cylinder. These trends were the same for the ESWT. When
looking at negative responders, 13 patients had an increase
in perceived breathlessness on the ISWT compared to
6 patients on the ESWT.
Discussion
There has been no previous study directly comparing an
endurance and maximal walking test looking at the relative
desaturation and sensitivity to ambulatory oxygen. Walking
tests are important for the practical assessment of ambu-
latory oxygen requirements. This study did not show any
statistical differences in desaturation for the ISWT and
ESWT between the three groups. This is contrary to
previous data where incremental cycling and endurance
walking have been employed and were shown to provoke
greater desaturation.15
This study shows significant differences in distance
walked between the baseline and the air, and between
air and oxygen for both the ISWT and the ESWT. We were
unable to identify statistical significant improvements for
perceived breathlessness or exertion scores at end of
exercise for the ISWT and ESWT for baseline, oxygen and
air. In the past it has been proposed as a useful indicator for
prescribing ambulatory oxygen.
We were, however, able to identify a cohort of responders
and non-responders to oxygen versus air employing a 10%
improvement in walking distance on the ISWT and ESWT evenafter completing a course of pulmonary rehabilitation. This
was based on original work by Lock et al. and has been
incorporated into recent guidelines.3 The ESWT showed
a greater percentage change 42.1% compared to 26.1% for
the ISWT, when considering ‘responders’. Equally the ESWT
also showed a greater percentage decrease in performance
for the non-responders, 56.1% compared to 5.0% for the
ISWT. Thus identifying that under comparable conditions
oxygen can enhance performance, but the weight of the cyl-
inder clearly impedes performance enhancement in this
population.
At present there are no clear guidelines for the pre-
scription of ambulatory oxygen in patients with COPD.
There are few studies comparing the immediate response
to oxygen in a single exercise test. Revill et al.16 reported
an increase in walking distance of 62 m on an ESWT when
on oxygen at a flow rate of 2 l/min1 compared to a baseline
walk. Like this current study patients had completed
a 7-week pulmonary rehabilitation programme. Garrod
et al.17 found that patients walked 27.3 m further on an
ISWT whilst breathing oxygen at 4 l/min1 compared to
air. The findings of this current study showed that patients
walked 32 m further on an ISWT whilst breathing oxygen at
2 l/min1 compared to air but only 4.5 m compared to base-
line. However, the data comprises responders and non-
responders.
Ambulatory oxygen is customarily defined as ‘‘oxygen
delivered by equipment that can be carried by most
patients’’.1 This study suggests that the current practice
of prescribing cylinders of oxygen may be ineffective,
not because oxygen has no benefit but the additional
weight of the cylinder compromises performance. Leggett
et al.18 also found that the weight of carrying an oxygen
cylinder removed any improvement in exercise tolerance
in a 12-min walk test. However, when the cylinder was
wheeled in a trolley the benefits of oxygen were restored.
A study by McDonald et al.19 used 5 kg cylinders and found
a significant difference in health related quality of life
(HRQL) in patients with COPD when comparing cylinder
air to oxygen at home. They concluded that the negative
effect of the weight excluded any benefit of oxygen.
Future efforts should be directed towards a widely avail-
able lightweight system for the benefits of oxygen to be
achieved.
Although ambulatory oxygen can be prescribed little
evidence exists about long-term compliance. An important
requirement for LTOT and non-LTOT patients who desatu-
rate on exercise may be the motivation to use ambulatory
oxygen outside the home. Eaton et al.20 found that despite
immediate improvements in 6 min walking distances with
supplementary oxygen after a 12-week double blind rando-
mised crossover study of oxygen versus cylinder air, a signif-
icant proportion of patients declined ambulatory oxygen
after completion of the study. Factors that have been pre-
viously reported as restricting use of ambulatory oxygen
include the weight, the limited autonomy and the equip-
ments lack of aesthetics.20 Future studies should examine
patient’s compliance in the domestic environment to ambu-
latory oxygen once it has been prescribed and explore how
the benefits might be quantified. Patient’s compliance to
ambulatory oxygen may be improved following a course of
pulmonary rehabilitation.
1152 C.J. Sandland et al.In our study patients did walk further with oxygen
compared to air for both the ISWT and the ESWT identifying
the benefit of oxygen compared to cylinder air but highlights
the limits of current systems. Patients also reported feeling
less breathless after the oxygen walks compared to the air
walks for both the ISWTand the ESWT.However, these results
were not significant. This study was double blinded and
therefore we were constrained to a standard gas flow of 2 l/
min1 to maintain the blinding. We acknowledge that some
patients may benefit from a higher flow rate. Leach et al.8
found that patients improved their walking distance by
67.7% whilst breathing oxygen at 4 l/min1 compared to
air. Practically this flow rate is difficult to administer as the
cylinders last approximately for 20 min at a flow rate of 4 l/
min1 compared with 2 h at a flow rate of 2 l/min1.
In this study the ESWT detected a greater number of
responders to supplementary oxygen therapy. However, the
level of desaturation for each test is equal. Therefore,
despite previous assumptions the mode of test doesn’t
appear to matter. Practically it is time consuming to
complete a testing regime of incremental and endurance
shuttle walking tests. It is therefore proposed that an ISWT
is a suitable exercise challenge that can be used to evaluate
desaturation and that a further ESWT is not required to
provoke a greater level of desaturation.Acknowledgements
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